London · Delayed Price · Currency is GBP · Price in GBX Genflow Biosciences Statistics
Total Valuation
LON:GENF has a market cap or net worth of GBP 10.48 million. The enterprise value is 9.84 million.
| Market Cap | 10.48M |
| Enterprise Value | 9.84M |
Important Dates
The next estimated earnings date is Tuesday, December 29, 2026.
| Earnings Date | Dec 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LON:GENF has 566.41 million shares outstanding. The number of shares has increased by 35.17% in one year.
| Current Share Class | 566.41M |
| Shares Outstanding | 566.41M |
| Shares Change (YoY) | +35.17% |
| Shares Change (QoQ) | +11.81% |
| Owned by Insiders (%) | 41.26% |
| Owned by Institutions (%) | 28.83% |
| Float | 325.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 17.41 |
| PB Ratio | 53.70 |
| P/TBV Ratio | 53.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 16.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.34
| Current Ratio | 1.34 |
| Quick Ratio | 1.28 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,177.57 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -112.91% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -579.22% |
| Weighted Average Cost of Capital (WACC) | 16.71% |
| Revenue Per Employee | 117,121 |
| Profits Per Employee | -220,036 |
| Employee Count | 5 |
| Asset Turnover | 0.96 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 2.26 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 2.00 |
| 200-Day Moving Average | 2.03 |
| Relative Strength Index (RSI) | 48.43 |
| Average Volume (20 Days) | 3,567,048 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:GENF had revenue of GBP 585,607 and -1.10 million in losses. Loss per share was -0.00.
| Revenue | 585,607 |
| Gross Profit | 585,607 |
| Operating Income | -1.10M |
| Pretax Income | -1.10M |
| Net Income | -1.10M |
| EBITDA | -1.10M |
| EBIT | -1.10M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 632,553 in cash and no debt, with a net cash position of 632,553 or 0.00 per share.
| Cash & Cash Equivalents | 632,553 |
| Total Debt | n/a |
| Net Cash | 632,553 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 189,853 |
| Book Value Per Share | 0.00 |
| Working Capital | 188,432 |
Cash Flow
In the last 12 months, operating cash flow was -1.23 million and capital expenditures -651, giving a free cash flow of -1.23 million.
| Operating Cash Flow | -1.23M |
| Capital Expenditures | -651 |
| Depreciation & Amortization | 781 |
| Net Borrowing | n/a |
| Free Cash Flow | -1.23M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 100.00%, with operating and profit margins of -187.78% and -187.87%.
| Gross Margin | 100.00% |
| Operating Margin | -187.78% |
| Pretax Margin | -187.87% |
| Profit Margin | -187.87% |
| EBITDA Margin | -187.65% |
| EBIT Margin | -187.78% |
| FCF Margin | n/a |
Dividends & Yields
LON:GENF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -35.17% |
| Shareholder Yield | -35.17% |
| Earnings Yield | -10.79% |
| FCF Yield | -12.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LON:GENF has an Altman Z-Score of -8.32 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.32 |
| Piotroski F-Score | 2 |